Health Products

Access Systems Assays (2017-05-08)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
All lots
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
Access Systems Assays33830

Introduction

Affected Products

A. 33830 Total T3 (Access System)
B. 33880 Free T4 (Access System)
C. 33860 Free T4 (Unicel Dxi 600 Access Immunoassay System)
D. 33830 Total T3 (Unicel Dxi 600 Access Immunoassay System)
E. 33860 Thyroglobulin (Unicel Dxi 600 Access Immunoassay System)
F. 387687 Gi Monitor (Unicel Dxi 600 Access Immunoassay System)
G. 33860 Thyroglobulin (Access System)
H. 387687 Gi Monitor (Access Immunoassay System)
I. 33880 Free T4 (Unicel Dxi 800 Access Immunoassay System)
J. 33830 Total T3 (Unicel Dxi 800 Access Immunoassay System)
K. 33860 Thyroglobulin (Unicel Dxi 800 Access Immunoassay System)
L. 387687 Gi Monitor (Unicel Dxi 800 Access Immunoassay System)

Reason

Beckman Coulter has determined through internal investigation and customer feedback that the affected assays are susceptible to biotin interference with patient samples containing 100 ng/ml of biotin. Specimens that contain high levels of biotin may cause: false low results for the access GI monitor and thyroglobulin assays, and may cause false high results for the access free T4 and total T3 assays.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime